key: cord-0708036-jtohycsh
authors: Gesek, Jakub; Jakimiuk, Katarzyna; Atanasov, Atanas G.; Tomczyk, Michał
title: Sanguiins—Promising Molecules with Broad Biological Potential
date: 2021-11-30
journal: Int J Mol Sci
DOI: 10.3390/ijms222312972
sha: 6d876097588aab947fc613a3f7c1f19199dbc223
doc_id: 708036
cord_uid: jtohycsh

Compounds of natural origin, an infinite treasure of bioactive chemical entities, persist as an inexhaustible resource for discovering new medicines. In this review, we summarize the naturally occurring ellagitannins, sanguiins, which are bioactive constituents of various traditional medicinal plants, especially from the Rosaceae family. In-depth studies of sanguiin H-6 as an antimicrobial, antiviral, anticancer, anti-inflammatory, and osteoclastogenesis inhibitory agent have led to potent drug candidates. In addition, recently, virtual screening studies have suggested that sanguiin H-6 might increase resistance toward SARS-CoV-2 in the early stages of infection. Further experimental investigations on ADMET (absorption, distribution, metabolism, excretion, and toxicity) supplemented with molecular docking and molecular dynamics simulation are still needed to fully understand sanguiins’ mechanism of action. In sum, sanguiins appear to be promising compounds for additional studies, especially for their application in therapies for a multitude of common and debilitating ailments.

Most of the discovered drugs are either drugs of natural origin or synthetic derivatives of natural compounds. Thus, a multidisciplinary approach to drug discovery and molecular diversity from natural product sources needs to be combined to provide the best solution to the problems with drug discovery and development [1, 2] . Plants are known to be a rich source of pharmacologically active secondary metabolites divided into structural chemical classes [3, 4] . One of the pharmacologically valuable classes of phytoconstituents are ellagitannins (ETs), and belonging to them, sanguiins. ETs, water-soluble phenolics, are esters of hexahydroxydiphenic acid and a polyol, usually β-D-glucose or quinic acid [5] [6] [7] . ET compounds demonstrate an enormous structural variability connected with various possibilities for the linkage of hexahydroxydiphenic residues with the glucose moiety and particularly by their easy susceptibility to creating dimeric and oligomeric derivatives [8] . The polyphenol-protein system and its interactions may underlie the medicinal properties exhibited by members of the ETs family. Fruits and nuts are rich sources of ellagitannins and are important in the human diet due to their properties as micronutrients [9, 10] . Due to the limited bioavailability of ellagitannins, as orally administered and the metabolic chemical changes as a result of their transit through the gastrointestinal tract, comprising of hydrolysis and gut microbiota metabolism, the activity of the produced metabolites also needs to be taken into consideration [3] .

Among various phenolic compounds isolated from the Rosaceae family, tannins and related compounds seem to have a leading position. It is known that plants previously used in folk medicine represent a suitable beginning to discover new potent drugs to treat various human disorders [15] . Sanguiins (Figure 1 ), naturally occurring ET, have been isolated chiefly from Rubus species and are used as a traditional drug to cure, e.g., diarrhea, menstrual pain, menopause disorders, liver diseases, aphtha, gingivitis, as well as fever, angina, enteritis, hepatitis, concretion, eczema, rheumatism, enterocolitis, bronchitis, prostate disorders, pain, cold, cough, and fever (Table 1) [16, 17] . Moreover, SH6 seems to be the most widespread within plants of the Rubus and is present in 22 species of this genus. Furthermore, the largest number of isolated and identified types of sanguiins, including SH2, SH4, SH5, SH6, and SH11, are found in Rubus coreanus [18] . Besides the Rubus genus, sanguiins and their isomers are found and reported in Alchemilla vulgaris, Alchemilla mollis [19] , Duchesnea indica [20] , Euphorbia fischeriana [21] , Fragaria vesca, Fragaria ananassa [22] , Punica granatum [23] , Terminalia calamansanai [24] , as well as in Sanguisorba officinalis [25] , and Sanguisorba tenuijolia var. alba [18] . isolated chiefly from Rubus species and are used as a traditional drug to cure, e.g., diarrhea, menstrual pain, menopause disorders, liver diseases, aphtha, gingivitis, as well as fever, angina, enteritis, hepatitis, concretion, eczema, rheumatism, enterocolitis, bronchitis, prostate disorders, pain, cold, cough, and fever (Table 1) [16, 17] . Moreover, SH6 seems to be the most widespread within plants of the Rubus and is present in 22 species of this genus. Furthermore, the largest number of isolated and identified types of sanguiins, including SH2, SH4, SH5, SH6, and SH11, are found in Rubus coreanus [18] . Besides the Rubus genus, sanguiins and their isomers are found and reported in Alchemilla vulgaris, Alchemilla mollis [19] , Duchesnea indica [20] , Euphorbia fischeriana [21] , Fragaria vesca, Fragaria ananassa [22] , Punica granatum [23] , Terminalia calamansanai [24] , as well as in Sanguisorba officinalis [25] , and Sanguisorba tenuijolia var. alba [18] . Among all sanguiins detected in plant material, only part of them was quantitatively analyzed. The place of harvest displays a relevant role in the amount of isolated sanguiins. For example, in Rubus fruticosus fruits, the range of detected SH6 is 135.04-547.48 mg/100 g of d.w. (dry weight) [26] and in Rubus idaeus shoots, 170.9-633.1 mg/100 g of d.w of the extract [27] . Following that, sanguiins content depends on fruits' ripeness, harvest time, climate, geographic location, and mineral nutrition [10, 28] . It is reported that in Rubus and Fragaria species, ellagitannins content represents a range of 50% to 80% of all phenolic compounds [10, 29] . In this review, the list of plants that produce sanguiins and their reported traditional uses are tabulated in Table 1 . Among all sanguiins detected in plant material, only part of them was quantitatively analyzed. The place of harvest displays a relevant role in the amount of isolated sanguiins. For example, in Rubus fruticosus fruits, the range of detected SH6 is 135.04-547.48 mg/100 g of d.w. (dry weight) [26] and in Rubus idaeus shoots, 170.9-633.1 mg/100 g of d.w of the extract [27] . Following that, sanguiins content depends on fruits' ripeness, harvest time, climate, geographic location, and mineral nutrition [10, 28] . It is reported that in Rubus and Fragaria species, ellagitannins content represents a range of 50% to 80% of all phenolic compounds [10, 29] . In this review, the list of plants that produce sanguiins and their reported traditional uses are tabulated in Table 1 . 

Chromatography displays a crucial role in the analysis of chemical compound mixtures. As a method for the separation and analysis of extracts and fractions from plants, it provides the possibility of qualitative and quantitative determination of the test substance with high resolution [67] . Chromatographic techniques and analysis conditions for detection, quantitative determination, and isolation of sanguiins and their isomers are given in Table 2 . 

Sanguiins, as one of the subgroups of polyphenolic ellagitannins, exhibit various pharmacological activities due to having different chemical structures. They possess a broad spectrum of pharmacological features such as anticancer, anti-inflammatory, antioxidant, osteoprotective, estrogenic, antibacterial, antifungal, and antiviral (including SARS-CoV-2), as shown in Table 3 . Various in vivo and in vitro investigations on sanguiins, especially on sanguiin H-6, have elucidated their medicinal characteristics and mechanisms of action [68, 69] . S. aureus inhibition: reduction in the growth from 10 9 CFU/mL to 10 3 CFU/mL 2.

E. coli inhibition: reduction in the growth from 10 9 CFU/mL to 10 7 CFU/mL 3.

L. plantarum inhibition: reduction in the growth from 8.0 × 10 8 CFU/mL to 6.0 × 10 8 CFU/mL 4.

C. perfringens inhibition: reduction in the growth from 7.0 × 10 8 CFU/mL to 2.0 × 10 8 CFU/mL 

One of the best-shown properties of polyphenols, and following that, sanguiins, is the potential antioxidant effect. Most references mention sanguiin H-6 as the primary compound having antioxidant activity, e.g., its influences on stress and oxidative damage were investigated. The production of peroxynitrite (ONOO-) was induced by the administration of lipopolysaccharide (LPS), followed by the induction of ischemia and reperfusion [88] . It was revealed that receiving SH6 before induction of oxidative damage could reduce the adverse effects associated with the release of ONOO-and enhance the improvement of injured kidney function [72] . Another chemical compound belonging to the sanguiins group that exhibits antioxidant activity is SH11. An examination of the protective effect of SH11 isolated from Sanguisorbae radix and its mechanism against glutamate-induced death in HT22 murine hippocampal cells exposed a significant reduction in glutamine-induced reactive oxygen radicals' accumulation and calcium ion influx [74] . Furthermore, ellagitannins from the berries of the Rubus family, including dimeric SH6 and SH10, function both as radical scavengers (in a DPPH test) and as antioxidants toward lipid oxidation in food emulsions (studied in bulk and emulsified methyl linoleate, in human low-density lipoprotein in vitro) [75] . The impact of sanguiins on the inflammation process was investigated by measuring their effect on rat neutrophils' chemotaxis. SH11 and SH6 effectively inhibited the cytokine-induced neutrophil chemoattractant migration process by 10.7% and 33%, respectively, in comparison with the control. Additionally, the study showed no toxic effect of sanguiin on neutrophils [70] . Furthermore, at a concentration of 2.5 µM, SH6 completely inhibited the release of IL-8 induced by tumor necrosis factor α and interleukin-1β and inhibited TNFα stimulated NF-κB transcription [71] . SH6 caused a concentration-dependent reduction in nitrite production, regression in induced NO synthase (iNOS) activity, and an increase in cell viability. Moreover, SH6 showed an apparent scavenging effect for NO generated from sodium nitroprusside (NO donor) [76] .

In a subsequent in vitro study, the action of Rubus parvifolius L. and its main component, SH6, was tested as the inhibitor of osteoclastogenesis and bone resorption. Sanguiin influence was based on the reduction in osteoclast differentiation and bone resorption, a decrease in the production of reactive oxygen species, as well as the inhibition of the nuclear translocation of the nuclear factor of activated T cells cytoplasmic-1 (NFATc1), c-Fos, and nuclear factor-κB. Additionally, sanguiin reduced the levels of NFATc1, cathepsin K, c-Src, and inhibited in vivo TNF-α-mediated osteoclastogenesis [47] .

The growing resistance of bacteria to currently used antibiotics is a growing problem in current medicine [89] . Increasingly emerging research on sanguine antibacterial properties gives hope for the discovery of antibacterial agents with the lack of unpleasant side effects. Examination of the antibacterial activity of fruits of selected Rubus species and compounds (SH6 and ellagic acid) against selected Gram-negative and Gram-positive bacteria allowed assessment of their usefulness in the fight against microorganisms. The results showed that SH6 was active against Streptococcus A (MIC = 0.5 mg/mL), Streptococcus pneumoniae (MIC = 0.5 mg/mL), Corynebacterium diphtheriae (MIC = 0.03 mg/mL), Bacillus subtilis (MIC = 0.5 mg/mL), Clostridium sporogenes (MIC = 0.06 mg/mL), Staphylococcus aureus (MIC = 0.25 mg/mL), Staphylococcus epidermidis (MIC = 0.125 mg/mL), and Moraxella catarrhalis (MIC = 0.5 mg/mL) [27] .

Additionally, another study showed that SH6 exhibited a significant inhibition level against S. aureus, E. coli, and C. perfringens [77] . Rubus ulmifolius fruit extract containing SH10, showed an antibacterial effect against Escherichia coli, Morganella morganii, and Proteus mirabilis, but higher extract concentrations were required: MIC = 5 mg/mL, MIC = 5 mg/mL, and MIC = 10 mg/mL, respectively [78] .

Moreover, Rubus ulmifolius fruit extract was tested as an antifungal agent. It was proved that the extract containing SH6 exhibited fungistatic activity against Candida albicans. The minimum inhibitory concentration was 5 mg/mL. Unfortunately, the extract did not show any fungicidal activity, achieving a result of >20 mg/mL [78] .

Viruses, as pathogenic microorganisms, show significant genetic variability and the ability to mutate. Often, they do not show signs of infection at first. Currently, an increasing number of drug-resistant strains, as well as the toxicity of previously known drugs, force researchers to develop new antiviral substances [90] . In recent months, the entire world has been severely affected by the SARS-CoV-2 pandemic, which has led scientists to focus their attention on potential candidates against its eradication. More and more recent research conducted worldwide shows that sanguiins may be a potential candidate in the fight against viral diseases, including COVID-19 [91, 92] . One of the studies predicted that SH6 is a compound that binds very well to the S1 and S2 subunits of the SARS-CoV-2 virus spine, which is responsible for entering the host cells and causing infection. SH6 showed the best binding energy among all tested compounds in the molecular docking assay. Additionally, SH2, also mentioned in the study, showed a lower result than the one mentioned above. Moreover, sanguiin has been proposed to act not only against the spike subunits of the SARS-CoV-2 virus [93] . Another molecular docking examination of polyphenolic compounds against the SARS-CoV-2 virus M pro protease revealed that SH6 had the best result of all tested compounds in the in silico model [80] . Moreover, the study performed by S. Luo et al. concerned the verification of bacterial neuraminidase inhibitory properties by nine compounds isolated from mock strawberry (Duchesnea indica Andr.). SH4 exhibited significant inhibitory activity in an in vitro model, which offers potential for its use as a new antiviral substance [20] .

Additionally studied features of sanguiins are their potential anticancer activity. Several investigations on SH6 have explained its anticancer effect due to its promising competency in inhibiting DNA topoisomerases I and II. Moreover, the compound acted as a blocker to HeLa cells. It inhibited their growth at an effective dose of 12 µM and also had a dose-dependent effect on intracellular topoisomerase activity. SH6 also exhibited significant antiangiogenic potential [82] . A study by Lee S. et al. on HT1080 human fibrosarcoma cells showed that this compound blocked KDR/Flk-1-Fc binding to VEGF165 in a dose-dependent manner. Moreover, the compound obstructed the VEGF-induced proliferation of HUVEC cells (IC 50 ca. = 7.4 µg/mL) but was not active against HT1080 human fibrosarcoma cells [83] .

The potential antitumor properties of sanguiins were also tested on PRMI-7951 melanoma cells. A moderate selective cytotoxicity was shown by SH2, SH6, and SH11 with ED 50 results of 0.44, 0.5, and 5.0 µg/mL, respectively [68] . Furthermore, anticancer activity was tested with SH4 isolated from Terminalia calamansanai leaves against large tumor cells lines, including human promyelocytic leukemia HL-60 cells. The compound induced a decrease in human poly (ADP-ribose) polymerase [79] (PARP) associated with the cleavage of procaspase-3 and exhibited strong activation of proapoptotic caspase-3 in HL-60 cells. It is worth mentioning that SH4 does not affect healthy cells, suggesting this compound is selective against cancer cells [24] . In another examination, SH6 was responsible for modulating the Smad 2/3 signaling pathway by TGF-β1, increasing the expression of the epithelial marker E-cadherin, repressing the expression of Snail and the mesenchymal marker N-cadherin during TGF-β1-induced EMT (epithelial-mesenchymal transition), and regulating the expression of EMT-dependent genes induced by TGF-β1. In summary, SH6 inhibits the migration and invasion of A549 lung cancer in vitro by inhibiting TGF-β1 induction of EMT [84] .

Moreover, SH6 showed a large number of antiproliferative, antimigration, and cytotoxic effects against human breast carcinoma cells. A study performed by Berdowska et al. proved that the tested compound exhibited an inhibitory effect on adriamycin-resistant cells (MCF-7/Adr) [85] . It also showed antimetastatic properties in MDA-MB-231 cells by reducing the expression of vascular endothelial growth factor (VEGF), phosphorylated Akt, and kinase 1/2 (ERK1/2) regulated by extracellular signals [86] . In addition, SH6 increased the ratio of Bax to Bcl-2 in both MCF-7 and MDA-MB-231 cells [79] .

SH6 was also studied for its activity against A2780 human ovarian carcinoma cells. The tested compound induced an antiproliferative effect and a morphological change similar to apoptotic cell death but did not arrest the cancer cell cycle. Moreover, SH6 showed an early apoptotic effect, caspase activation, PARP cleavage, activation of mitogen-activated protein kinases (MAPKs), especially p38, and an increase in truncated p15/BID [87] .

SH6 has also been tested for estrogenic activity against MCF-7 human breast cancer cells. The E-screen examination and the molecular docking analysis showed that the SH6 from Rubus coreanus exhibited the best binding energy of −250,149 kcal/mol. Additionally, at 100 µg/mL, R. coreanus extract significantly stimulated cell proliferation (574.57% ± 8.56%). The study results indicated that SH6 contributed to the estrogenic activity of R. coreanus by activating the ERα coactivator binding site [81] .

Rubus L. subgenus R. watson, R. brigantinus, and R. vagabundus extracts containing SH2, SH6, and SH10 were tested for their potential neuroprotective properties against SK-N-MC neuroblastoma cells. All digested extracts after 2 and 24 h of preincubation reduced basal ROS production. Rubus brigantinus and R. vagabundus extracts increased the mitochondrial transmembrane potential and the integrity of the cell membrane. Moreover, the extracts increased GSH levels while not changing the GSH/GSSG ratio. It is worth mentioning that there is insufficient evidence for the interaction of brain endothelial cells with polyphenol metabolites, which makes it difficult to determine the level of the passage of the compound across the blood-brain barrier [62] .

As mentioned above, the efficacy of sanguiins is mainly limited to preclinical studies. However, there has been some research on black raspberry and pomegranate food products in clinical trials. Considering the fact that these products are rich in ellagitannins, it can be concluded that the biological activity may also be connected with the occurrence of sanguiins in the juice from berries and pomegranate. Nevertheless, there is a lack of information on clinical studies that use only sanguiins in medical treatment [44, 94, 95] .

Sanguiins, belonging to the ellagitannin group, show similar pharmacokinetics. In vitro studies have shown that ellagitannins are stable in the gastric environment, and in the presence of gastric enzymes, they are not hydrolyzed to ellagic acid. In addition, the absorption of ellagitannins in the stomach is impracticable due to their complex chemical structure. However, free ellagic acid molecules can be absorbed in the stomach. On the other hand, the intestinal environment, together with the gastrointestinal microbiota, creates suitable conditions for their hydrolysis and decomposition into urolithins and their derivatives, which pass through the intestinal wall into the enterohepatic circulation [96] . In addition, in vivo studies have shown that the metabolism of SH6 and SH10 in the liver is partly based on conjugation with glucuronic acid and sulfuric acid, leading to the formation of compounds such as urolithin A-O-glucuronide, urolithin A-sulfate, and urolithin B-3-O-glucuronide. Moreover, urolithins were detected in the unconjugated form. Conjugation of derivatives occurs at different rates and intensities; T max of plasma urolithin glucuronides and sulfates is achieved in the vast majority of compounds 24 h after administration. Ultimately, conjugated and unconjugated compounds are excreted in the urine at varying intervals, up to 48 h after ingestion. Further in vivo clinical studies linked to full pharmacokinetic analysis are necessary to fully determine the participation of urolithins in the therapeutic effects of ellagitannin-rich plants [3, 97, 98] .

The isolation and structure determination, accompanied by the measurement of the diverse pharmacological activities of each isolated sanguiin, has brought about a marked change in the concept of these compounds as active components of medicinal plants. In summary, sanguiins, especially sanguiin H-6, show evidence of promising action in various biological contexts, particularly in respect of their anticancer, antiradical, and antiviral properties. Apart from that, further studies involving drug delivery may improve the effectiveness of these compounds toward the drug target sites. Furthermore, it is worth considering performing a supplementary survey on their metabolism and toxicology patterns with molecular docking and molecular dynamics simulation to understand their mechanisms of action fully. 

The authors declare no conflict of interest. bone marrow-derived macrophages NFATC1T max nuclear factor of activated T cells 1time take to reach maximum concentration

Natural products as sources of new drugs over the 30 years from 1981 to 2010

Natural products in drug discovery: Advances and opportunities

Ellagitannins, gallotannins and their metabolites-The contribution to the anti-inflammatory effect of food products and medicinal plants

Astragalin: A bioactive phytochemical with potential therapeutic activities

Ellagitannins-Nature, occurrence and dietary burden

Relationship between phenolic compounds, anthocyanins content and antioxidant activity in colored barley germplasm

Total synthesis of sanguiin H-5

Enzymology of gallotannin and ellagitannin biosynthesis

Ellagitannin chemistry. the first total chemical synthesis of an O(2),O(3)-Galloyl-Coupled ellagitannin, sanguiin H-5

Food ellagitannins-occurrence, effects of processing and storage

Contents of anthocyanins and ellagitannins in selected foods consumed in Finland

Synthesis of Sanguiin H-5. Synfacts

A dimeric hydrolyzable tannin, sanguiin H-6 from Sanguisorba officinalis L

Flavonoids of the Caryophyllaceae

Ellagitannins, ellagic acid and their derived metabolites: A review about source, metabolism, functions and health

Therapeutic constituents and actions of Rubus species

Phytochemical composition and potential use of Rubus species

Hydrolysable tannins as chemotaxonomic markers in the Rosaceae

Phenolic constituents from Alchemilla vulgaris L. and Alchemilla mollis (Buser) Rothm. at different dates of harvest

Rapid identification and isolation of neuraminidase inhibitors from mockstrawberry (Duchesnea indica Andr.) based on ligand fishing combined with HR-ESI-Q-TOF-MS

Allose gallates from Euphorbia fischeriana

Clarifying the identity of the main ellagitannin in the fruit of the strawberry, Fragaria vesca and Fragaria ananassa Duch

Rapid and comprehensive evaluation of polyphenolic compounds in pomegranate (Punica granatum L.) juice by UHPLC-MS

Ellagitannins from Terminalia calamansanai induced apoptosis in HL-60 cells

Tannins and related compounds. CXXII. New dimeric, trimeric and tetrameric ellagitannins, lambertianins A-D, from Rubus lambertianus SERINGE

Rubus fruticosus (blackberry) use as an herbal medicine

The antimicrobial activity of fruits from some cultivar varieties of Rubus idaeus and Rubus occidentalis

Structural features and biological properties of ellagitannins in some plant families of the order myrtales

Tannins: Structural Properties, Biological Properties and Current Knowledge

Phenolic profiling of Duchesnea indica combining macroporous resin chromatography (MRC) with HPLC-ESI-MS/MS and ESI-IT-MS

Bioactivity of Fragaria vesca leaves through inflammation, proteasome and autophagy modulation

Two new and four known polyphenolics obtained as new cell-cycle inhibitors from Rubus aleaefolius poir

Hepatoprotection of 1β-hydroxyeuscaphic acid-The major constituent from Rubus aleaefolius against CCl4-induced injury in hepatocytes cells

Analysis of phenolic compounds in two blackberry species (Rubus glaucus and Rubus adenotrichus) by high-performance liquid chromatography with diode array detection and electrospray ion trap mass spectrometry

Impact of industrial processing and storage on major polyphenols and the antioxidant capacity of tropical highland blackberry (Rubus adenotrichus)

Impact of agrochemicals on Peronospora sparsa and phenolic profiles in three Rubus arcticus cultivars

Phenolic extracts of Rubus ulmifolius Schott flowers: Characterization, microencapsulation and incorporation into yogurts as nutraceutical sources

Natural antimicrobials from cloudberry (Rubus chamaemorus) seeds by sanding and hydrothermal extraction

Protein-phenolic interaction of tryptic digests of β-lactoglobulin and cloudberry ellagitannin

Rubus chamaemorus L.-A boreal plant rich in biologically active metabolites: A review

In vitro antiproliferative and antioxidant effects of extracts from Rubus caesius leaves and their quality evaluation

Determination of phenolic compounds and antioxidant activity in leaves from wild Rubus L. species

Characterization of black raspberry functional food products for cancer prevention human clinical trials

Edible Medicinal and Non-Medicinal Plants: Fruits

Chemical composition and biological activity of Rubus idaeus shoots-A traditional herbal remedy of Eastern Europe

Sanguiin H-6, a constituent of Rubus parvifolius L., inhibits receptor activator of nuclear factor-κB ligand-induced osteoclastogenesis and bone resorption in vitro and prevents tumor necrosis factor-α-induced osteoclast formation in vivo

Anti-hyperglycemic and antihyperlipidemic effects of the triterpenoid-rich fractions from Rubus coreanus and Rubus crataegifolius and their main component, niga-ichigoside f1, in streptozotocin-induced diabetic rats

Characterization of carotenoids and phenolics during fruit ripening of Chinese raspberry

An overview of botany, traditional uses, phytochemistry, and pharmacology. Chin

A new active compound against kidney deficiency from the fruits of Rubus corchorifolius

Profiling and accurate quantification of Rubus ellagitannins and ellagic acid conjugates using direct UPLC-Q-TOF hdms and HPLC-DAD analysis

Role of human gut microbiota metabolism in the anti-inflammatory effect of traditionally used ellagitannin-rich plant materials

The complete chloroplast genome of tibetan medicinal plant Rubus phoenicolasius Maxim

Structural identification of the main ellagitannins of a boysenberry (Rubus loganbaccus × baileyanus Britt.) extract by LC-ESI-MS/MS, MALDI-TOF-MS and NMR spectroscopy

Hydrolyzable tannins from the fruits of Rubus coreanum

Tannins from the leaves of Rubus coreanum

Comparative study on antioxidant effects of extracts from Rubus coreanus and Rubus occidentalis Lee

Chemical composition of blackberry press cake, polyphenolic extract, and defatted seeds, and their effects on cecal fermentation, bacterial metabolites, and blood lipid profile in rats

HPLC analysis of polyphenols in the fruits of Rubus idaeus L. (Rosaceae)

Neuroprotective effects of digested polyphenols from wild blackberry species

Tannins and related compounds. Part 3. A new phenolic acid, sanguisorbic acid dilactone, and three new ellagitannins, sanguiins H-1, H-2, and H-3, from Sanguisorba officinalis

Traditional uses, chemical constituents and biological activities of plants from the genus Sanguisorba L

Punica granatum: A review on pharmacological and therapeutic properties

Existing knowledge on Euphorbia fischeriana Steud. (Euphorbiaceae): Traditional uses, clinical applications, phytochemistry, pharmacology and toxicology

Recent trends in the application of chromatographic techniques in the analysis of luteolin and its derivatives

Tannins and related compounds as selective cytotoxic agents

Phytotherapeutic activities of Sanguisorba officinalis and its chemical constituents: A review

Inhibitory effect of sanguiin H-11 on chemotaxis of neutrophil

Ellagitannins from Rubus berries for the control of gastric inflammation: In vitro and in vivo studies

Potential of sanguiin H-6 against oxidative damage in renal mitochondria and apoptosis mediated by peroxynitrite in vivo

Ellagitannins, flavonoids, and other phenolics in red raspberries and their contribution to antioxidant capacity and vasorelaxation properties

Sanguiin H-11 from Sanguisorbae radix protects HT22 murine hippocampal cells against glutamate-induced death

Antioxidant activity of isolated ellagitannins from red raspberries and cloudberries

Effects of sanguiin H-6, a component of Sanguisorbae radix, on lipopolysaccharidestimulated nitric oxide production

Antimicrobial activities of ellagitannins against Clostridiales perfringens, Escherichia coli, Lactobacillus plantarum and Staphylococcus aureus

Rubus ulmifolius Schott fruits: A detailed study of its nutritional, chemical and bioactive properties

Cytotoxic effect of sanguiin H-6 on MCF-7 and MDA-MB-231 human breast carcinoma cells

Identification of potential inhibitors of dietary polyphenols for SARS-CoV-2 M protease: An in silico study

Estrogenic activity of sanguiin H-6 through activation of estrogen receptor α coactivator-binding site

Inhibition of DNA topoisomerases by sanguiin H-6, a cytotoxic dimeric ellagitannin from Sanguisorba officinalis

Sanguiin H-6 blocks endothelial cell growth through inhibition of VEGF binding to VEGF receptor

Sanguiin H6 suppresses TGF-β induction of the epithelial-mesenchymal transition and inhibits migration and invasion in A549 lung cancer

Fecka, I. Modulatory impact of selected ellagitannins on the viability of human breast cancer cells

Assessment of the anti-metastatic properties of sanguiin H-6 in HUVECs and MDA-MB-231 human breast cancer cells

Inhibition of A2780 human ovarian carcinoma cell proliferation by a Rubus component, sanguiin H-6

Direct scavenging of nitric oxide by traditional crude drugs

Antibiotic resistance

A review of the antiviral susceptibility of human and avian influenza viruses over the last decade

A review of SARS-CoV-2 and the ongoing clinical trials

Human coronaviruses a review of virus-host interactions

Identification of ellagitannins as natural inhibitors of spike proteins of COVID19 virus: An in silico-based study for drug development

Pharmacokinetics of anthocyanins and ellagic acid in healthy volunteers fed freeze-dried black raspberries daily for 7 days

The cholesterol-lowering effect of unripe Rubus coreanus is associated with decreased oxidized LDL and apolipoprotein B levels in subjects with borderline-high cholesterol levels: A randomized controlled trial

The structure, occurrence and biological activity of ellagitannins: A general review

Biological significance of urolithins, the gut microbial ellagic acid-derived metabolites: The evidence so far. Evid.-Based Complement

New insights into the bioavailability of red raspberry anthocyanins and ellagitannins. Free Radic